The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis
- PMID: 21037042
- PMCID: PMC2966362
- DOI: 10.4065/mcp.2010.0336
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis
Abstract
Objective: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD).
Patients and methods: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk.
Results: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD.
Conclusion: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.
Figures
Similar articles
-
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.Am J Epidemiol. 2012 Apr 15;175(8):793-803. doi: 10.1093/aje/kwr384. Epub 2012 Mar 16. Am J Epidemiol. 2012. PMID: 22427612 Free PMC article.
-
Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients.Mayo Clin Proc. 2013 May;88(5):479-86. doi: 10.1016/j.mayocp.2013.01.025. Epub 2013 Apr 4. Mayo Clin Proc. 2013. PMID: 23562348 Free PMC article.
-
Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients.Am J Kidney Dis. 2014 Apr;63(4):612-22. doi: 10.1053/j.ajkd.2013.07.021. Epub 2013 Oct 9. Am J Kidney Dis. 2014. PMID: 24120224 Free PMC article.
-
Obesity paradox in end-stage kidney disease patients.Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):415-25. doi: 10.1016/j.pcad.2013.10.005. Epub 2013 Oct 9. Prog Cardiovasc Dis. 2014. PMID: 24438733 Free PMC article. Review.
-
Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis.Nephron Clin Pract. 2012;121(3-4):c102-11. doi: 10.1159/000345159. Epub 2012 Nov 22. Nephron Clin Pract. 2012. PMID: 23182883 Review.
Cited by
-
Shorter length dialysis sessions are associated with increased mortality, independent of body weight.Kidney Int. 2013 Jan;83(1):104-13. doi: 10.1038/ki.2012.346. Epub 2012 Sep 26. Kidney Int. 2013. PMID: 23014457 Free PMC article.
-
In-Center Nutrition Practices of Clinics within a Large Hemodialysis Provider in the United States.Clin J Am Soc Nephrol. 2016 May 6;11(5):770-775. doi: 10.2215/CJN.09270915. Epub 2016 Apr 15. Clin J Am Soc Nephrol. 2016. PMID: 27084879 Free PMC article.
-
[Obesity and cardiac cachexia in chronic heart failure].Herz. 2013 Sep;38(6):610-7. doi: 10.1007/s00059-013-3885-0. Herz. 2013. PMID: 23897599 Review. German.
-
Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.Antioxid Redox Signal. 2016 Oct 20;25(12):685-701. doi: 10.1089/ars.2015.6569. Epub 2016 Jul 27. Antioxid Redox Signal. 2016. PMID: 27287984 Free PMC article. Review.
-
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.Am J Epidemiol. 2012 Apr 15;175(8):793-803. doi: 10.1093/aje/kwr384. Epub 2012 Mar 16. Am J Epidemiol. 2012. PMID: 22427612 Free PMC article.
References
-
- United States Renal Data System USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. In: National Institutes of Health NIoDaDaKD , ed. USRDS Annual Report. Bethesda, MD: NIH/NIDDK; 2008. http://www.usrds.org/atlas_2006.htm Accessed August 6, 2010
-
- Chertow GM, Hsu CY, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006;17:1501-1502 - PubMed
-
- Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925-1932 - PubMed
-
- Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med. 2009;122:1106-1114 - PubMed
